HFCIX
MDLN

H&F Corporate Investors X’s Medline Inc MDLN Stock Holding History

H&F Corporate Investors X’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.8B Sell
70,874,326
-15,599,171
-18% -$629M 100% 1
2026
Q1 		$3.85B Sell
86,473,497
-13,040,572
-13% -$576M 100% 1
2025
Q4 		$4.18B Buy
+99,514,069
New +$4.2B 100% 1

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

H&F Corporate Investors X's MDLN Position: Q2 2026 in Review

H&F Corporate Investors X reduced its Medline Inc (MDLN) stake by 18% in Q2 2026, selling an estimated $629M and leaving 70,874,326 shares worth $2.8B. The position accounts for 100% of the portfolio, ranked #1.

H&F Corporate Investors X first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.18B in Q4 2025. 408 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • H&F Corporate Investors X held 70,874,326 shares of Medline Inc worth $2.8B as of Q2 2026.
  • H&F Corporate Investors X sold 15,599,171 Medline Inc shares in Q2 2026, an estimated $629M.
  • Medline Inc made up 100% of H&F Corporate Investors X's portfolio in Q2 2026, its #1 holding.
  • H&F Corporate Investors X first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • H&F Corporate Investors X's Medline Inc position peaked at $4.18B in Q4 2025.
  • 408 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on H&F Corporate Investors X's 13F filing for Q2 2026, filed 12 Aug 2026.